A three-month placebo-controlled study determined that the use of Bio-Strath® can slow or reverse the development of geriatric disorders. The general condition of patients receiving Bio- Strath® tablets or liquid improved significantly compared to placebo as did short-term memory, physical exercise tests, recovery time and age related physical symptoms. The results of an overall medical assessment improved by 82% in those who received Bio-Strath® liquid, 66% in those who received tablets and only 27% in those on placebo.
Pelke, R.B., H. Leuchtgens, and W.U. Weitbrecht, Pre-geriatric Study on Bio-Strath® Notabene Medici Journal für Ärzte, 1990. 3&4: p. 122-125 & 196-201.
Patients between the age of 57 and 84 with advanced geriatric symptoms, the majority of which had pre-Alzheimer’s problems were given Bio-Strath® for 3 months or placebo. Those who received Bio-Strath® experienced significant improvements over placebo with regards to fatigue, headaches, dizziness, sleep problems as well as improved mental alertness, emotional stability and mood. Overall geriatric symptom scores (GESY) also improved significantly as did the ability to speak numbers backwards (a highly demanding psychometric test), scores measuring other related geriatric diseases also improved significantly compared to placebo.
Pelka, R. and H. Leuchtgens, Pre-Alzheimer- Study – Action of herbal yeast preparaiton (Bio-Strath®) in a randomised double-blind trial Ars Medici, 1995. 85(1)
Influence of Bio-Strath® on osteogenesis
A laboratory-based bone density study found that the application of Bio-Strath® caused bone building (osteoblast) cells to mature & develop, in addition Bio-Strath® reduced the formation of cells that break down bone (osteoclasts), when treating osteoporosis ideally there should be more osteoblast activity and less osteoclast activity. Bio-Strath® does this by producing two proteins known to prevent osteoporosis (OPG & RUNX2). When combined with a combination of bone building substances Bio-Strath® resulted in an enhanced effect suggesting that Bio-Strath® in combination with drug therapy could be successful in osteoporosis.
Monici, M., et al., Herbal yeast plasmolysate promotes the osteogenic differentiation of human mesenchymal stem cells. L’Integratore Nutrizionale, 2011. 14(1): p. 37-42.